ALDR Market Cap History
Below is a table of the ALDR market cap history going back to 5/8/2014:

Date ALDR Market Cap

Also see: ALDR Shares Outstanding History
and ALDR YTD Return
ALDR Historical Market Cap:
+13.33% CAGR
ALDR Historical Market Cap: +13.33% CAGR

Mouse over chart for data details
5/8/2014 ...12/31/2018
Alder Biopharmaceuticals is a clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize therapeutic antibodies with the potential to transform the treatment paradigm in migraine. Co. is focusing on eptinezumab (ALD403). Eptinezumab is a humanized immunoglobulin G1 monoclonal antibody for calcitonin gene-related peptide ligand, a small protein and a target to drive migraine initiation, maintenance and chronification. Co.'s product candidate pipeline also includes ALD1910, a neutralizing monoclonal antibody with reactivity to that targets pituitary adenylate cyclase-activating polypeptide-38. We show 24 historical shares outstanding datapoints in our ALDR shares outstanding history coverage, used to compute ALDR market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ALDR market cap history over the course of time is important for investors interested in comparing ALDR's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ALDR versus a peer is one thing; comparing ALDR market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ALDR can fluctuate over the course of history. With this page we aim to empower investors researching ALDR by allowing them to research the ALDR market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree ALDR Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Alder Biopharmaceuticals (ALDR) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

ALDX Market Cap History
ALEC Market Cap History
ALGN Market Cap History
ALGS Market Cap History
ALHC Market Cap History
ALIM Market Cap History
ALKS Market Cap History
ALLK Market Cap History
ALLO Market Cap History
ALNA Market Cap History
More Healthcare companies »


ALDR Market Cap History | | Copyright © 2017 - 2022, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.